Business
Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea
Initial commercial orders for the Apyx One console in South Korea are expected in Q4 2025CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the approval and commercial launch of the Apyx One console and single-use handpieces in South Korea following the recent regulatory approval by the Ministry of
About this update from Apyx Medical Corporation
[{"type":"image","alt":"Apyx Medical Corporation","displaySize":"","headline":null,"caption":"Apyx Medical Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/f776ee7f25241f6a4c93b21ba8aff893"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WNW7RVUw1wUG.ea_dTVO0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f776ee7f25241f6a4c93b21ba8aff893","width":300,"height":157}},"lazy":false},{"type":"text","content":"Initial commercial orders for the Apyx One console in South Korea are expected in Q4 2025","length":89,"tagName":"p"},{"type":"text","content":"CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the approval and commercial launch of the Apyx One console and single-use handpieces in South Korea following the recent regulatory approval by the Ministry of Food and Drug Safety (MFDS). The Company plans to start shipping Apyx One consoles and single-use handpieces to South Korea to fill initial orders starting in the fourth quarter of 2025.","length":598,"tagName":"p"},{"type":"text","content":"The Apyx One console is a multi-functional generator incorporating an advanced 3-in-1 energy system that enables plastic and cosmetic surgeons to utilize Renuvion technology, together with full monopolar and bipolar energy. Key features of the Apyx One console include adaptive and intuitive touch screens, procedural presets by body part, quantification of energy delivered to a body area, and an advanced gas system that measures and monitors gas volume and usage.","length":466,"tagName":"p"},{"type":"text","content":"“Seoul is widely regarded as the cosmetic surgery capital of the world, supported by a thriving medical tourism industry. We are excited to launch commercial sales of the Apyx One console in South Korea, where the cosmetic surgery market is estimated to be $1.7 billion in 2024 and projected to exceed $3.9 billion by 20331,” said Charlie Goodwin, President and CEO of Apyx Medical Corporation. “Much like in the U.S. and Europe, the GLP-1 weight-loss drug market in South Korea has grown rapidly over the past...